BMED – BlackRock Future Health ETF
BlackRock Future Health ETF (BMED) is a Health ETF, issued by BlackRock, $7.7M in assets, 0.85% expense ratio.
Returns as of Oct 23, 2026: 1 week +2.0%, 1 year +21.5%.
Invests 80%+ in health sciences companies. Focuses on human health products and services, with potential investments in animal and plant health.
Top holdings
- JNJ – Johnson & Johnson, 3.4%
- ROG – Roche Holding AG, 3.4%
- MDT – Medtronic PLC, 3.0%
- EXAS – EXACT Sciences Corporation, 2.9%
- GH – Guardant Health Inc, 2.7%
- MRK – Merck & Company Inc, 2.7%
- GILD – Gilead Sciences Inc, 2.6%
- EW – Edwards Lifesciences Corp, 2.5%
- NTRA – Natera Inc, 2.1%
- GEN – Genmab A/S, 2.0%
- NOVN – Novartis AG, 2.0%
- MRNA – Moderna Inc, 2.0%
- A – Agilent Technologies Inc, 1.9%
- ABT – Abbott Laboratories, 1.9%
- PODD – Insulet Corporation, 1.9%
- ILMN – Illumina Inc, 1.8%
- RGEN – Repligen Corporation, 1.7%
- AMGN – Amgen Inc, 1.6%
- TMO – Thermo Fisher Scientific Inc, 1.6%
- DHR – Danaher Corporation, 1.6%
- SRT3 – Sartorius Aktiengesellschaft, 1.5%
- LONN – Lonza Group AG, 1.5%
- CRL – Charles River Laboratories, 1.5%
- BIIB – Biogen Inc, 1.4%
- ISRG – Intuitive Surgical Inc, 1.4%